Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety ...

Centene fell by 11.1 percent week-on-week, from $31.44 on July 11 to $27.95 last Friday—a new all-time low, as investors turned cautious ahead of its second quarter earnings results, further ...

However, for Q1 2025, Centene Corporation (NYSE:CNC) stated that premium and service revenues rose by 17% to $42.5 billion ...

This was the stock's third consecutive day of losses.

UnitedHealth stock has plunged over 40% in 2025 and is approaching a key buy zone ahead of the Q2 2025 earnings.

UnitedHealth Group continues to slide as the broader healthcare sector shows persistent signs of weakness. Check out why I ...

Elevance Health (NYSE:ELV), and several other leading players in the Marketplace insurance exchanges established under the ...

The Indianapolis company reduced its 2025 earnings target to $24.10 a share from a prior estimated range between $28.30 and $29 a share. On an adjusted basis, Elevance cut its projection to $30 a ...

This was the stock's second consecutive day of losses.

Analysts have provided Elevance Health with 11 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $476.73, suggesting a potential 41.8% upside.

Defense stocks, fast moving foreign banks, Tesla, Alphabet and others will be in focus for stock market investors in the coming week.

Analysts generally have a positive outlook for Elevance Health, with an ‘Outperform’ consensus rating and a decent potential ...